430 related articles for article (PubMed ID: 14710003)
1. Long-term results after interval therapy with intratympanic gentamicin for Menière's disease.
Lange G; Maurer J; Mann W
Laryngoscope; 2004 Jan; 114(1):102-5. PubMed ID: 14710003
[TBL] [Abstract][Full Text] [Related]
2. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
Wu IC; Minor LB
Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
[TBL] [Abstract][Full Text] [Related]
3. Intratympanic gentamicin for intractable Meniere's disease.
Perez N; Martín E; García-Tapia R
Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
[TBL] [Abstract][Full Text] [Related]
4. Intratympanic gentamicin therapy for intractable Ménière's disease.
De Beer L; Stokroos R; Kingma H
Acta Otolaryngol; 2007 Jun; 127(6):605-12. PubMed ID: 17503229
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Ménière's disease by low-dosage intratympanic gentamicin application: effect on otolith function.
Helling K; Schönfeld U; Clarke AH
Laryngoscope; 2007 Dec; 117(12):2244-50. PubMed ID: 17909448
[TBL] [Abstract][Full Text] [Related]
6. [Intratympanic gentamicin treatment for intractable Menière's disease].
Gilony D; Wolf M; Kronenberg J
Harefuah; 2004 Jan; 143(1):4-7, 88. PubMed ID: 14748278
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Ménière's disease by intratympanic gentamicin application.
Assimakopoulos D; Patrikakos G
J Laryngol Otol; 2003 Jan; 117(1):10-6. PubMed ID: 12590850
[TBL] [Abstract][Full Text] [Related]
8. Intratympanic gentamicin therapy for control of vertigo in unilateral Menire's disease: a prospective, double-blind, randomized, placebo-controlled trial.
Postema RJ; Kingma CM; Wit HP; Albers FW; Van Der Laan BF
Acta Otolaryngol; 2008 Aug; 128(8):876-80. PubMed ID: 18607963
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Ménière's disease with "on-demand" intratympanic gentamicin injections.
Manrique-Huarte R; Guillén-Grima F; Perez-Fernandez N
Otol Neurotol; 2011 Apr; 32(3):461-5. PubMed ID: 21317673
[TBL] [Abstract][Full Text] [Related]
10. [Intratympanic treatment in Meniere's disease: the effect of gentamicin and dexamethasone on vertigo control and hearing].
Akkuzu B; Ozgirgin N; Ozlüoğlu LN
Kulak Burun Bogaz Ihtis Derg; 2006; 16(5):193-9. PubMed ID: 17124437
[TBL] [Abstract][Full Text] [Related]
11. Long-term disability of class A patients with Ménière's disease after treatment with intratympanic gentamicin.
Boleas-Aguirre MS; Sánchez-Ferrandiz N; Guillén-Grima F; Perez N
Laryngoscope; 2007 Aug; 117(8):1474-81. PubMed ID: 17607149
[TBL] [Abstract][Full Text] [Related]
12. Intratympanic gentamicin injection for the treatment of Meniere's disease.
Youssef TF; Poe DS
Am J Otol; 1998 Jul; 19(4):435-42. PubMed ID: 9661751
[TBL] [Abstract][Full Text] [Related]
13. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease.
Horii A; Saika T; Uno A; Nishiike S; Mitani K; Nishimura M; Kitahara T; Fukushima M; Nakagawa A; Masumura C; Sasaki T; Kizawa K; Kubo T
Otol Neurotol; 2006 Sep; 27(6):896-900. PubMed ID: 16788414
[TBL] [Abstract][Full Text] [Related]
14. Intratympanic gentamicin for Ménière's disease: effect on quality of life as assessed by Glasgow benefit inventory.
Banerjee AS; Johnson IJ
J Laryngol Otol; 2006 Oct; 120(10):827-31. PubMed ID: 16707038
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
Derebery MJ; Fisher LM; Berliner K; Chung J; Green K
Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
[TBL] [Abstract][Full Text] [Related]
16. Intratympanic gentamicin treatment in Meniere's disease: patients' experiences and outcomes.
Smith WK; Sandooram D; Prinsley PR
J Laryngol Otol; 2006 Sep; 120(9):730-5. PubMed ID: 16848921
[TBL] [Abstract][Full Text] [Related]
17. Hearing results following intratympanic gentamicin perfusion for Ménière's disease.
Kyrodimos E; Aidonis I; Sismanis A
J Laryngol Otol; 2009 Apr; 123(4):379-82. PubMed ID: 18954493
[TBL] [Abstract][Full Text] [Related]
18. Low dose transtympanic gentamicin treatment for intractable Meniere's disease: a prospective study.
Kasemsuwan L; Jariengprasert C; Ruencharopen S; Orathai P
J Med Assoc Thai; 2007 Feb; 90(2):327-34. PubMed ID: 17375639
[TBL] [Abstract][Full Text] [Related]
19. Low-dose intratympanic gentamicin treatment for dizziness in Ménière's disease.
Longridge NS; Mallinson AI
J Otolaryngol; 2000 Feb; 29(1):35-9. PubMed ID: 10709170
[TBL] [Abstract][Full Text] [Related]
20. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
Silverstein H; Wazen J; Van Ess MJ; Daugherty J; Alameda YA
Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
